Next Article in Journal
Pinelliae Rhizoma, a Toxic Chinese Herb, Can Significantly Inhibit CYP3A Activity in Rats
Next Article in Special Issue
Facile Access to Unnatural Dipeptide-Alcohols Based on cis-2,5-Disubstituted Pyrrolidines
Previous Article in Journal
Pharmacological Profile of Xanthohumol, a Prenylated Flavonoid from Hops (Humulus lupulus)
Previous Article in Special Issue
Synthesis and X-ray Structural Studies of a Substituted 2,3,4,5-Tetrahydro-1H-3-benzazonine and a 1,2,3,5-Tetrahydro-4,3-benzoxazonine
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

A Novel One-Pot Green Synthesis of Dispirooxindolo-pyrrolidines via 1,3-Dipolar Cycloaddition Reactions of Azomethine Ylides

1
Department of Chemistry, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia
2
Centro de Química-Física Molecular and Institute of Nanoscience and Nanotechnology, Instituto Superior Técnico, Universidade de Lisboa, Lisboa 1049-001, Portugal
3
Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia
4
Crystallography Unit, School of Physics, Universiti Sains Malaysia, Penang 11800, Malaysia
*
Author to whom correspondence should be addressed.
Molecules 2015, 20(1), 780-791; https://doi.org/10.3390/molecules20010780
Submission received: 1 December 2014 / Accepted: 30 December 2014 / Published: 7 January 2015

Abstract

:
A facile synthesis of dispirooxindolopyrrolidines has been accomplished via a one-pot three component 1,3-dipolar cycloaddition reaction. The reaction of azomethine ylides generated in situ from L-phenylalanine and substituted isatins with a series of unusual (E)-2-oxoindolino-3-ylidene acetophenone dipolarophiles in the ionic liquid 1-butyl-3-methylimidazolium bromide [bmim]BF4, furnished the cycloadducts in good yields, with the regioisomers 5af being obtained with high selectivity. Furthermore, the recyclability of [bmim]BF4, up to five times, was also investigated.

Graphical Abstract

1. Introduction

Ionic liquids are widely recognized as “green” solvents in organic synthesis because of their unique properties, such as low vapor pressure, high chemical and thermal stability, good solvating ability, non-flammability, behavior as acidic or basic catalysts and recyclability [1,2,3,4,5]. In this context, ionic liquids have emerged as new green solvents to replace volatile organic compounds and they are suitable for executing many diverse organic reactions [6,7,8]. One-pot three component reactions, widely useful in both combinatorial and medicinal chemistry arenas, with their powerful bond forming and atom efficiencies, represent another eco-friendly synthetic approach for the expedient construction of molecules of structural diversity and complexity [9,10,11,12]. These reactions also assume importance from the viewpoint of minimized waste generation due to the avoidance of intermediate isolation and purification steps. For these reasons, the development of multi-component reactions in ionic liquids, although relatively unexplored [13], is of great interest.
The spirooxindole core is a privileged heterocyclic system that is featured in a large number of bioactive naturally occurring alkaloids (Figure 1) that display a wide spectrum of biological activities such as antimicrobial [14], inhibition of human NK-1 receptor [15] and potent non-peptide inhibition of the p53–MDM2 interaction [16]. Particularly, the spiropyrrolidinyloxindole nucleus is often found in the molecular framework of many natural products, viz., horsfiline [17], coerulescine [18], and elacomine [19] (Figure 1) which possess a myriad of biological activities such as inhibition of the mammalian cell cycle at G2/Mphase [20,21], inhibition of microtubule assembly [22], modulation of the function of muscarinic serotonin receptors [23], antitumor activity against human brain cancer cell lines, neuroblastoma SKN-BE (2), and malignant glioma GAMG [24].
Figure 1. Biologically relevant spirooxindolopyrrolidine alkaloids and natural products.
Figure 1. Biologically relevant spirooxindolopyrrolidine alkaloids and natural products.
Molecules 20 00780 g001
The biological significance of the above heterocycles prompted us to explore the synthesis of novel hybrid spiroheterocycles comprising pyrrolidine and oxindole units via a one-pot three component 1,3-dipolar cycloaddition reaction. Recently, we embarked on a program for the synthesis and/or biological screening of structurally diverse novel spiroheterocycles, which has brought to light various antimicrobial leads [25,26,27,28]. In continuation of our research in the area of 1,3-dipolar cycloaddition reactions [29,30], herein we wish to report an expeditious and facile protocol for the synthesis of dispirooxindolopyrrolidines in ionic liquid medium; highly desirable from the viewpoint of green chemistry. Furthermore, to the best of our knowledge, this is the first report on the generation of azomethine ylide from L-phenylalanine and isatin in ionic liquid medium.

2. Results and Discussion

In the present investigation, the one-pot three component reaction of (E)-2-oxoindolino-3-ylidene acetophenones 4ab with non-stabilized azomethine ylides 3, generated in situ by the decarboxylative condensation of isatin 1ac and L-phenylalanine (2) in [bmim]BF4 afforded the dispiropyrrolidines 5af in good yields (70%–77%) with selectivity, along with trace amounts of the regioisomers 6af (5%–7%) (Scheme 1).
Scheme 1. Synthesis of dispirooxindolopyrrolidines 5af and 6af.
Scheme 1. Synthesis of dispirooxindolopyrrolidines 5af and 6af.
Molecules 20 00780 g004
Solvent-optimization for this cycloaddition reaction was investigated by the reaction of an equimolar ratio of (E)-2-oxoindolino-3-ylidene acetophenone, isatin and L-phenylalanine in organic solvents viz. methanol, ethanol, dioxane, dioxane/methanol (1:1) mixture under heating in an oil-bath (Table 1). The cycloadducts 5a and 6a were obtained only in 28%and 12% yield in methanol (Table 1, entry 1), whilst the reactions in ethanol, dioxane and dioxane/methanol (1:1) mixture furnished the products 5a and 6a in 30% and 15%, 34% and 16%, 38% and 18% yields, respectively, which indicated that the solvents had little effect on the selectivity and yield of the reaction (Table 1). The same reaction was also investigated in ionic liquids, such as [bmim]Br, [bmim]BF4 and also with combination of a catalyst, [bmim][BF4]/CuI (10 mol %), [bmim][BF4]/Zn(OTf)2 (10 mol %). Like the reactions in organic solvents, these reactions also furnished 5a and 6a, but with good yield and high selectivity, the isomer 5 being obtained predominantly in all cases. The ionic liquids [bmim]BF4 and [bmim]Br were found to be the appropriate reaction medium for these cycloaddition reactions in terms of yield and selectivity (Table 1, entry 6). Hence, all the subsequent reactions were performed by heating an equimolar mixture of the reactants in [bmim]BF4 (3 mL) in an oil-bath at 100 °C for 2 h (Table 2). After completion of the reaction (by TLC), the product was isolated and purified by flash column chromatography, while the [bmim]BF4was recovered by vacuum distillation then dried under vacuum at 40 °C overnight for recycling (Table 3).
Table 1. Solvent condition and yield optimization of cycloaddition reaction.
Table 1. Solvent condition and yield optimization of cycloaddition reaction.
EntrySolvent SystemYield (%)Time (h)
5a6a
1Methanol28126
2Ethanol30156
3Dry Dioxane34165
4Dioxane/Methanol38184
5[bmim]Br6982
6[bmim][BF4]7772
7[bmim][BF4]/CuI (10 mol %)60152
8[bmim][BF4]/Zn(OTf)2 (10 mol %)62182
Notes: Optimized reaction condition is in bold (entry 6); Ionic liquids were subjected to high vacuum before use (entry 5–8).
Table 2. Yield and distereoselectivity of the cycloadducts 5af and 6af.
Table 2. Yield and distereoselectivity of the cycloadducts 5af and 6af.
EntryDerivatives (a–f)Yield of the Cycloadducts (%) #Diastereoselectivity (5/6)
56
1a77791/9
2b70585/15
3c75689/11
4d73590/10
5e72588/12
6f71587/13
Note: # All reactions were carried out with [bmim]BF4 ionic liquid under 2 h refluxion.
Table 3. Reusability of the ionic liquid in the synthesis of 5a and 6a.
Table 3. Reusability of the ionic liquid in the synthesis of 5a and 6a.
ExperimentFirstSecondThirdFourthFifth
[Bmim]Br(Yield %)69:867:763:661:460:3
[Bmim]BF4(Yield %)77:775:672:568:465:3
The structure of regioisomers was elucidated using IR, 1H-, 13C-NMR spectroscopic and mass spectrometry studies. For instance, the IR spectrum of the cycloadduct 5a displayed characteristic bands at 1628, 1706, 1710 cm−1 corresponding to the two oxindoles and benzoyl carbonyls, respectively. In the 1H-NMR spectrum of 5a, the benzylic and Ha protons appeared as multiplets in the region δH 3.08–3.12 and 5.57–5.61 ppm, respectively. The Hb proton attached to the benzoyl group appeared as doublet at δH 4.29 ppm and the trans stereochemistry was confirmed through coupling constant of Hb proton (J = 8.8 Hz). The aromatic protons appear as multiplets around 6.43–7.78 ppm. In the 13C-NMR spectrum, the signals at δC 177.2, 180.5 and 195.4 ppm were attributed to two oxindole and benzoyl ring carbonyls. The two spiro carbons resonated at δC 63.9 and 83.3 ppm. Furthermore, the presence of the molecular ion peak at m/z 533 (M+) in the mass spectrum of 5a supported the formation of the cycloadduct. The stereochemistry of compound 5a has been assigned based on the fact that the carbonyls of the two isatin rings are in trans relationship as to minimize the repulsion between the two isatin carbonyl as evidenced in the literature [31,32,33]. The structure of other regioisomer 6a was also elucidated by similar straight forward considerations. The singlet at δH 4.90 ppm in the 1H-NMR spectrum, confirms the formation of regioisomer 6a. A pictorial representation of the 1H- and 13C-NMR chemical shifts of 5a and 6a is shown in Figure 2.
Figure 2. Selected 1H- and 13C-NMR signals of compounds 5a and 6a.
Figure 2. Selected 1H- and 13C-NMR signals of compounds 5a and 6a.
Molecules 20 00780 g002
A rational mechanism for the formation of the cycloadducts 5 and 6 in the presence of [bmim]BF4 is described in Scheme 2. It is known that ionic liquid play dual roles as solvent and catalyst. For instance, the hydrogen atom of [bmim]+, being electron-deficient can form hydrogen bonds with heteroatoms thereby catalyzing reactions. Thus, in the present transformation, a hydrogen bond between the imidazole ring hydrogen atom of [bmim]+ and the carbonyl group of 4 furnishes 4', which readily reacts with azomethine ylide to afford 5 and 6. The azomethine ylide may also be catalyzed by [bmim]BF4 via hydrogen bonding. This catalysis presumably expedites the reaction in ionic liquid relative to other solvents.
Scheme 2. Plausible mechanism for the synthesis of dispirooxindolopyrrolidine regioisomers.
Scheme 2. Plausible mechanism for the synthesis of dispirooxindolopyrrolidine regioisomers.
Molecules 20 00780 g005
The regio- and stereo- chemistry of cycloadduct 6f was further supported by single crystal X-ray diffraction studies [34] (Figure 3). The molecule 6f is composed of a central pyrrolidine ring with benzoyl group at C9, benzyl group at C11, spiro-carbons fused with oxindoles at C7 and C10 (Figure 3). The dihedral angle between the pyrrolidine ring A (N2/C7/C9/C10/C11), indolin-2-one ring B (C1-C8/N1) and 2,3-dihydro-1H-inden-1-one ring C (C19-C26) are 77.96(2)°, 84.72(3)° and 24.07(2)° for A/B, A/C and B/C, respectively. The torsion angle in between C11-N2-C7-C9 is 40.0(2)°. There are three intramolecular interactions between C9–H9A···O3, C11–H11A···O1 and C20–H20A···O1. In the crystal structure, seven intermolecular N–H···O and C–H···O hydrogen bonds are observed. The selected geometric parameters and distances of the donor–H, acceptor/H, donor/acceptor and donor–H/acceptor angles are presented in Tables S1 and S2 (vide Supplementary Data).
Figure 3. ORTEP diagram of 6f, showing the atom-numbering. Displacement ellipsoids are drawn at the 40% probability level and all H-atoms are shown as small spheres of arbitrary radii.
Figure 3. ORTEP diagram of 6f, showing the atom-numbering. Displacement ellipsoids are drawn at the 40% probability level and all H-atoms are shown as small spheres of arbitrary radii.
Molecules 20 00780 g003

3. Experimental Section

3.1. General Methods

Melting points were taken using open capillary tubes and are uncorrected. Unless stated otherwise, solvents and chemicals were obtained from commercial sources and used without further purification. IR Spectra were measured as KBr pellets on a Nicolet 6700 FT-IR spectrophotometer (Madison, WI, USA). 1H- and 13C-NMR spectra were recorded on a Varian Mercury JEOL-400 NMR spectrometer (Tokyo, Japan) and Bruker 500 MHz NMR spectrometers (Faellanden, Switzerland) operating at 400, 500, 100 and 125 MHz, respectively, and chemical shifts are reported as δ values (ppm) relative to tetramethylsilane. Elemental analyses were performed on a Perkin-Elmer 2400 series II elemental CHNS analyser (Waltham, MA, USA). Flash column chromatography was performed on silica gel (230–400 mesh) using petroleum ether (60–80 °C)/EtOAc as eluent.

3.2. General Procedure for Synthesis of Dispirooxindoles 5af and 6af

A mixture of isatin (1 mmol), L-phenylanaine (1 mmol) and (E)-2-oxoindolino-3-ylidene acetophenone (1 mmol) was heated with stirring in [bmim]BF4 medium (3 mL) for 2 h at 100 °C. After completion of the reaction as evidenced by TLC analysis, ethyl acetate (10 mL) was added and the reaction mixture was stirred for 10–15 min. The organic layer was separated and removed under reduced pressure. The crude cycloadducts were isolated through flash column chromatography. The ionic liquid [bmim]BF4 after extraction of the product was dried under vacuum at 40 °C for 2 h overnight to eliminate any water trapped from moisture and reused for subsequent runs.
(2′R,3′R,4′S,5′S)-4′-(4-Chlorobenzoyl)-5′-benzyl-spiro[3,2′]oxindolo-spiro[3,3″]oxindolopyrrolidine (5a). Colorless solid (290 mg, 77%), mp 195–197 °C (EtOAc); RF 0.4 (pet. ether/EtOAc, 1:1); IR (KBr): 1628, 1706 and 1710 cm−1; 1H-NMR (400 MHz, CDCl3): δH 7.78–6.43 (m, 17H, aromatic), 5.61–5.57 (m, 1H), 4.29 (d, J = 8.8 Hz, 1H), 3.12–3.08 (m, 2H); 13C-NMR (100 MHz, CDCl3): δC 195.4, 180.5, 177.2, 141.3, 140.3, 138.8, 138.2, 135.9, 130.0, 129.8, 129.4, 128.9, 128.8, 128.5, 127.7, 126.6, 125.6, 125.3, 124.3, 122.6, 109.5, 109.3, 83.3, 63.9, 61.4, 59.5, 40.8. LC/MS (ESI): m/z 533 [M]+. Anal. Calcd for: C32H24ClN3O3: C, 71.97; H, 4.53; N, 7.87. Found: C, 71.81; H, 4.68; N, 7.93%.
(2′S,3′S,4′S,5′S)-3′-(4-Chlorobenzoyl)-5′-benzyl-spiro[3,2′]oxindolo-spiro[3″,4′]oxindolopyrrolidine (6a). Colorless solid (26 mg, 7%), mp 162–164 °C (EtOAc); RF 0.5 (pet. ether/EtOAc, 1:1); IR (KBr): 1626, 1708 and 1710 cm−1; 1H-NMR (400 MHz, CDCl3): δH 7.69–6.37 (m, 17H, aromatic), 5.01–4.98 (m, 1H), 4.90 (s, 1H), 2.97–2.94 (m, 1H), 2.69–2.65 (dd, J = 13.9, 4.4 Hz, 1H); 13C-NMR (100 MHz, CDCl3): δC 197.3, 180.8, 175.6, 141.3, 140.2, 139.6, 135.5, 131.3, 129.5, 128.8, 128.6, 128.4, 128.4, 128.4, 128.2, 127.8, 126.3, 125.3, 124.8, 122.6, 110.0, 109.8, 88.6, 69.4, 68.6, 61.6, 36.5. LC/MS (ESI): m/z 533 [M]+. Anal. Calcd for: C32H24ClN3O3: C, 71.97; H, 4.53; N, 7.87. Found: C, 71.88; H, 4.65; N, 7.96%.
(2′R,3′R,4′S,5′S)-4′-Benzoyl-5′-benzyl-spiro[3,2′]oxindolo-spiro[3,3″]oxindolopyrrolidine (5b). Color-less solid (281 mg, 70%), mp 145–147 °C (EtOAc); RF 0.4 (pet. ether/EtOAc, 1:1); IR (KBr): 1628, 1706 and 1710 cm−1; 1H-NMR (500 MHz, CDCl3): δH 6.31–7.42 (m, 16H, aromatic), 5.56–5.54 (m, 1H), 4.30 (d, J = 8.8 Hz, 1H), 3.04–3.02 (m, 2H); 13C-NMR (125 MHz, CDCl3): δC 196.7, 181.0, 177.7, 177.7, 141.5, 140.5, 138.3, 137.6, 132.5, 129.9, 129.4, 128.7, 128.6, 128.6, 128.4, 128.2, 127.5, 126.4, 125.5, 125.4, 124.4, 122.4, 109.6, 109.2, 83.9, 63.9, 61.2, 59.5, 40.7. LC/MS (ESI) m/z 499 [M]+; Anal. Calcd for: C32H25N3O3: C, 76.94; H, 5.04; N, 8.41. Found: C, 76.88; H, 5.16; N, 8.52%.
(2′S,3′S,4′S,5′S)-3′-Benzoyl-5′-benzyl-spiro[3,2′]oxindolo-spiro[3″,4′]oxindolopyrrolidine (6b). Color-less solid (20 mg, 5%), mp 117–119 °C (EtOAc); RF 0.5 (pet. ether/EtOAc, 1:1); IR (KBr): 1628, 1706 and 1710 cm−1; 1H-NMR (500 MHz, CDCl3): δH 7.48–6.26 (m, 18H, aromatic), 5.39–5.37 (m, 1H), 4.88 (s, 1H), 3.48–3.47 (m, 1H), 3.17–3.16 (m, 1H); 13C-NMR (125 MHz, CDCl3): δC 197.9, 179.8, 174.6, 142.2, 141.1, 139.8, 137.3, 132.5, 129.5, 129.1, 128.9, 128.2, 128.4, 128.3, 128.1, 127.5, 126.3, 125.8, 125.5, 121.1, 109.6, 109.5, 75.2, 67.1, 64.8, 61.3, 39.7. LC/MS (ESI) m/z 499 [M]+; Anal. Calcd for: C32H24N3O3: C, 76.94; H, 5.04; N, 8.41. Found: C, 76.85; H, 5.21; N, 8.54%.
(2′R,3′R,4′S,5′S)-4′-(4-Chlorobenzoyl)-5′-benzyl-5-chlorospiro[3,2′]oxindolo-spiro[3,3″]oxindolo-pyrrolidine (5c). Pale yellow solid (301 mg, 75%), mp 205–207 °C (EtOAc); RF 0.4 (Pet. Ether/EtOAc, 1:1); IR (KBr): 1625, 1708 and 1710 cm−1; 1H-NMR (400 MHz, CDCl3): δH 8.31 (s, 1H, NH), 8.29 (s, 1H, NH), 7.48–6.45 (m, 16H, aromatic), 5.57–5.51 (m, 1H), 4.26 (d, J = 8.1, 1H), 3.08–3.03 (m, 2H); 13C-NMR (100 MHz, CDCl3): δC 195.3, 177.2, 140.5, 140.2, 138.2, 139.0, 135.8, 130.0, 129.3, 129.0, 128.9, 128.5, 127.9, 127.6, 127.1, 126.6, 126.1, 124.0, 122.7, 110.8, 109.6, 83.0, 63.7, 61.5, 59.4, 41.0. LC/MS (ESI) m/z 567 [M]+; Anal. Calcd. for: C32H23Cl2N3O3: C, 67.61; H, 4.08; N, 7.39. Found: C, 67.76; H, 4.19; N, 7.47%.
(2′S,3′S,4′S,5′S)-3′-(4-Chlorobenzoyl-5′-benzyl)-5-chlorospiro[3,2′]oxindolo-spiro[3″,4′]oxindolo-pyrrolidine (6c). Pale yellow solid (24 mg, 6%), mp 187–189 °C (EtOAc); RF 0.5 (Pet. Ether/EtOAc, 1:1); IR (KBr): 1625, 1708 and 1710 cm−1; 1H-NMR (400 MHz, CDCl3): δH 8.71 (s, 1H, NH), 8.53 (s, 1H, NH), 5.16 (s, 1H), 7.66–6.29 (m, 16H, aromatic), 5.00–4.96 (m, 1H), 3.52–3.46 (m, 1H), 3.26–3.23 (m, 1H); 13C-NMR (100 MHz, CDCl3): δC 195.3, 177.2, 180.4, 139.0, 138.2, 135.8, 129.7, 129.5, 129.2, 128.8, 128.4, 128.5, 128.3, 128.0, 127.1, 126.6, 125.2, 122.6, 110.1, 83.0, 63.7, 61.5, 41.0. LC/MS (ESI) m/z 567 [M]+; Anal. Calcd for: C32H23Cl2N3O3: C, 67.61; H, 4.08; N, 7.39. Found: C, 67.74; H, 4.21; N, 7.43%.
(2′R,3′R,4′S,5′S)-4′-Benzoyl-5′-benzyl-5-chlorospiro[3,2′]oxindolo-spiro[3,3″]oxindolopyrrolidine (5d). Colorless solid (312 mg, 73%), mp 155–157 °C (EtOAc); RF 0.4 (pet. ether/EtOAc, 1:1); IR (KBr): 1628, 1706 and 1710 cm−1; 1H-NMR (500 MHz, CDCl3): δH 9.79 (s, 1H, NH), 9.77 (s, 1H, NH), 7.47–6.30 (m, 17H, aromatic), 5.54–5.49 (m, 1H), 4.24 (d, J = 8.0, 1H), 3.18–3.02 (m, 2H); 13C-NMR (125 MHz, CDCl3): δC 196.8, 180.0, 177.0, 141.6, 141.2, 137.4, 138.6, 132.3, 129.5, 129.1, 129.0, 128.7, 128.4, 128.3, 128.0, 127.9, 127.1, 126.7, 126.1, 124.3, 123.7, 122.6, 121.7, 110.7, 110.0, 85.5, 64.9, 61.3, 59.8, 41.0. LC/MS (ESI) m/z 533 [M]+; Anal. Calcd for: C32H24ClN3O3: C, 71.97; H, 4.53; N, 7.87. Found: C, 71.89; H, 4.45; N, 7.95%.
(2′S,3′S,4′S,5′S)-3′-Benzoyl-5′-benzyl-5-chlorospiro[3,2′]oxindolo-spiro[3″,4′]oxindolopyrrolidine (6d). Colorless solid (21 mg, 5%), mp 144–145 °C (EtOAc); RF 0.5 (pet. ether/EtOAc, 1:1); IR (KBr): 1628, 1706 and 1710 cm−1; 1H-NMR (500 MHz, CDCl3): δH 9.73 (s, 1H, NH), 9.16 (s, 1H, NH), 7.15–6.09 (m, 17H, aromatic), 5.22 (s, 1H), 4.76–4.72 (m, 1H), 3.32–3.30 (m, 1H), 3.03–2.99 (m, 1H); 13C-NMR (125 MHz, CDCl3): δC 197.7, 179.7, 174.5, 141.3, 141.1, 139.5, 137.2, 132.5, 131.9, 129.4, 129.2, 128.4, 128.2, 128.0, 127.5, 126.2, 126.0, 121.2, 110.3, 75.1, 64.8, 61.3, 39.6. LC/MS (ESI) m/z 533 [M]+; Anal. Calcd for: C32H24ClN3O3: C, 71.97; H, 4.53; N, 7.87. Found: C, 71.86; H, 4.49; N, 7.25%.
(2′R,3′R,4′S,5′S)-4′-(4-Chlorobenzoyl)-5′-benzyl-5-nitrospiro[3,2′]oxindolo-spiro[3,3″]oxindolo-pyrrolidine (5e). Reddish brown solid (294 mg, 72%), mp 232–234 °C (EtOAc); RF 0.3 (pet. ether/EtOAc, 1:1); IR (KBr): 1625, 1708 and 1710 cm−1; 1H-NMR (400 MHz, CDCl3): δH 8.85 (s, 1H, NH), 8.62 (s, 1H, NH), 8.41–6.54 (m, 16H, aromatic), 5.54 (m, 1H),4.34 (d, J = 8.8 Hz, 1H), 3.16–3.05 (m, 2H); 13C-NMR (100 MHz, CDCl3): δC 195.2, 180.3, 177.5, 147.7, 143.3, 140.6, 139.3, 138.1, 135.6, 129.4, 129.3, 129.0, 128.7, 128.6, 126.7, 126.4, 123.6, 122.8, 122.0, 110.1, 110.0, 83.1, 63.7, 61.9, 59.4, 40.9. LC/MS (ESI) m/z 578 [M]+; Anal. Calcd for: C32H23ClN4O5: C, 66.38; H, 4.00; N, 9.68. Found: C, 66.47; H, 4.16; N, 9.75%.
(2′S,3′S,4′S,5′S)-3′-(4-Chlorobenzoyl)-5′-benzyl-5-nitrospiro[3,2′]oxindolo-spiro[3″,4′]oxindolo-pyrrolidine (6e). Reddish brown solid (20 mg, 5%), mp 210–212 °C (EtOAc); RF 0.4 (pet. ether/EtOAc, 1:1); IR (KBr): 1625, 1708 and 1710 cm−1; 1H-NMR (400 MHz, CDCl3): δH 9.13 (s, 1H, NH), 7.99 (s, 1H, NH), 7.75–6.47 (m, 16H, aromatic), 5.31 (s, 1H), 5.03–5.01 (m, 1H), 3.51–3.45 (m, 1H), 3.28–3.25 (dd, 12.4, 4.4 Hz, 1H); 13C-NMR (100 MHz, CDCl3): δC 195.7, 180.8, 174.5, 147.5, 142.6, 139.5, 138.9, 135.3, 129.8, 129.4, 128.9, 128.9, 128.7, 128.5, 127.7, 128.0, 126.9, 125.4, 124.5, 123.2, 110.2, 75.1, 65.0, 61.0, 42.1. LC/MS (ESI) m/z 578 [M]+; Anal. Calcd for: C32H23ClN4O5: C, 66.38; H, 4.00; N, 9.68. Found: C, 66.49; H, 4.14; N, 9.79%.
(2′R,3′R,4′S,5′S)-4′-Benzoyl-5′-benzyl-5-nitrospiro[3,2′]oxindolo-spiro[3,3″]oxindolopyrrolidine (5f). Brown solid (310 mg, 71%), mp 197–199 °C (EtOAc); RF 0.3 (pet. ether/EtOAc, 1:1); IR (KBr): 1625, 1708 and 1710 cm−1; 1H-NMR (500 MHz, CDCl3): δH 8.33 (s, 1H, NH) 7.96 (s, 1H, NH), 7.65–6.31 (m, 17H, aromatic), 5.30–5.25 (m, 1H), 4.32 (d, J = 8.7 Hz, 1H), 3.06–3.02 (m, 2H); 13C-NMR (125 MHz, CDCl3): δC 195.5, 180.5, 176.2, 149.3, 140.8, 141.7, 137.7, 136.4, 132.8, 129.6, 129.4, 128.8, 128.5, 128.4, 128.0, 126.4, 125.6, 125.2, 123.1, 120.8, 109.4, 83.1, 68.1, 61.2, 55.9, 40.1. LC/MS (ESI): m/z 544 [M]+; Anal. Calcd for: C32H24N4O5: C, 70.58; H, 4.44; N, 10.29. Found: C, 70.66; H, 4.37; N, 10.18%.
(2′S,3′S,4′S,5′S)-3′-Benzoyl-5′-benzyl-5-nitrospiro[3,2′]oxindolo-spiro[3″,4′]oxindolopyrrolidine (6f). Brown needles (21 mg, 5%), mp 175–177 °C (EtOAc/DMSO, 9:1); RF 0.4 (pet. ether/EtOAc, 1:1); IR (KBr): 1625, 1708 and 1710 cm−1; 1H-NMR (500 MHz, CDCl3): δH 10.28 (s, 1H, NH), 9.24 (s, 1H, NH), 7.70–6.22 (m, 17H, aromatic), 4.76–4.74 (m, 1H), 5.15 (s, 1H), 3.28–3.25 (m, 1H), 2.93–2.88 (m, 1H); 13C-NMR (125 MHz, CDCl3): δC 197.3, 180.3, 174.1, 148.9, 141.1, 137.3, 132.7, 130.8, 129.4, 128.4, 128.2, 127.9, 127.5, 126.2, 126.0, 124.9, 121.5, 110.0, 109.3, 74.7, 64.9, 61.2, 55.8, 39.9. LC/MS (ESI) m/z 544 [M]+; Anal. Calcd for: C32H24N4O5: C, 70.58; H, 4.44; N, 10.29. Found: C, 70.68; H, 4.35; N, 10.21%.

3.3. X-ray Crystallography

A clear intense yellow block-like specimen of C37H36N3O7S2, approximate dimensions 0.39 × 0.457 × 0.674 mm, was used for the X-ray crystallographic analysis. A total of 684 frames were collected. The total exposure time was 2.85 h. The frames were integrated with the Bruker SAINT software package [35] using a narrow-frame algorithm. The integration of the data using a monoclinic unit cell, space group P21/n, yielded a total of 35419 reflections to a maximum θ angle of 28.33° (0.75 Å resolution), of which 8504 were independent (average redundancy 5.743, completeness = 99.6%, Rint = 3.18%, Rsig = 2.93%) and 6264 (76.53%) were greater than 2σ(F2). The final cell constants of a = 13.5273(5) Å, b = 14.8582(6) Å, c = 17.1768(7) Å, β = 95.0630(10)°, volume = 3437.3(2) Å3, are based upon the refinement of the XYZ-centroids of 9790 reflections above 20 σ(I) with 4.588° < 2θ < 56.36°. Data were corrected for absorption effects using the multi-scan method (SADABS). The ratio of minimum to maximum apparent transmission was 0.907. The calculated minimum and maximum transmission coefficients (based on crystal size) are 0.9490 and 0.9690.
The final anisotropic full-matrix least-squares refinement on F2 with 388 variables converged at R1 = 6.41%, for the observed data and wR2 = 20.09% for all data. The goodness-of-fit was 1.06. The largest peak in the final difference electron density synthesis was 8.210 e-/Å3 and the largest hole was −1.079 e-/Å3 with an RMS deviation of 0.325 e-/Å3. On the basis of the final model, the calculated density was 1.067 g/cm3 and F(000) 1468.

4. Conclusions

A one-pot three component 1,3-dipolar cycloaddition reaction of azomethine ylide generated in situ from substituted isatins and L-phenylalanine to (E)-2-oxoindolino-3-ylidene acetophenones in [bmim]BF4 afforded the dispirooxindolopyrrolidines 5af and 6af in good yields with high selectivity, the former isomer being obtained predominantly. This methodology gains importance as the reaction was completed in shorter reaction times with better yields/selectivity besides the recyclability of the green solvent [bmim]BF4.

Supplementary Materials

Supplementary materials can be accessed at: https://www.mdpi.com/1420-3049/20/01/0780/s1.

Acknowledgments

The authors acknowledge the Deanship of Scientific Research at King Saud University for the Research Grant No. RGP-VPP-026.

Author Contributions

A.I.A., N.A., R.S.K. and G.P. are design, synthesis and characterization of the molecules. X-ray crystallographic analysis by H.A.G. and H.-K.F. The manuscript was written by N.A.

Conflicts of Interest

The authors declare no conflicts of interest.

References and Notes

  1. Welton, T. Room-temperature ionic liquids. Solvents for synthesis and catalysis. Chem. Rev. 1999, 99, 2071–2084. [Google Scholar] [CrossRef] [PubMed]
  2. Petkovic, M.; Seddon, K.R.; Rebelo, L.P.N.; Pereira, C.S. Ionic liquids: A pathway to environmental acceptability. Chem. Soc. Rev. 2011, 40, 1383–1403. [Google Scholar] [CrossRef] [PubMed]
  3. Yao, Q. OsO4 in ionic liquid [Bmim]PF6: A recyclable and reusable catalyst system for olefin dihydroxylation. Remarkable effect of DMAP. Org. Lett. 2002, 4, 2197–2199. [Google Scholar] [CrossRef]
  4. Kumar, A.; Pawar, S.S. Converting exo-selective Diels-Alder reaction to endo-selective in chloroloaluminate ionic liquids. J. Org. Chem. 2004, 69, 1419–1420. [Google Scholar] [CrossRef] [PubMed]
  5. Fukumoto, K.; Yoshizawa, M.; Ohno, H. Room temperature ionic liquids from 20 natural amino acids. J. Am. Chem. Soc. 2005, 127, 2398–2399. [Google Scholar] [CrossRef] [PubMed]
  6. Forsyth, S.A.; Frohlich, U.; Goodrich, P.; Gunaratne, H.Q.N.; Hardacre, C.; McKeown, A.; Seddon, K.R. Functionalised ionic liquids: Synthesis of ionic liquids with tethered basic groups and their use in Heck and Knoevenagel reactions. New J. Chem. 2010, 34, 723–731. [Google Scholar] [CrossRef]
  7. Gao, J.; Song, Q.-W.; He, L.-N.; Liu, C.; Yang, Z.-Z.; Han, X.; Li, X.-D.; Song, Q.-C. Preparation of polystyrene-supported Lewis acidic Fe(III) ionic liquid and its application in catalytic conversion of carbon dioxide. Tetrahedron 2012, 68, 3835–3842. [Google Scholar] [CrossRef]
  8. Narayana Kumar, G.G.K.S.; Aridoss, G.; Laali, K.K. Condensation of propargylic alcohols with indoles and carbazole in [bmim][PF6]/Bi(NO3)3·5H2O: A simple high yielding propargylation method with recycling and reuse of the ionic liquid. Tetrahedron Lett. 2012, 53, 3066–3069. [Google Scholar]
  9. Ramon, D.J.; Yus, M. Asymmetric multicomponent reactions (AMCRs): The new frontier. Angew. Chem. Int. Ed. 2005, 44, 1602–1634. [Google Scholar] [CrossRef]
  10. Sunderhaus, J.D.; Martin, S.F. Applications of multicomponent reactions to the synthesis of diverse heterocyclic scaffolds. Chem. Eur. J. 2009, 15, 1300–1308. [Google Scholar] [CrossRef] [PubMed]
  11. Isambert, N.; Lavilla, R. Heterocycles as key substrates in multicomponent reactions: The fast lane towards molecular complexity. Chem. Eur. J. 2008, 14, 8444–8454. [Google Scholar] [CrossRef] [PubMed]
  12. Orru, R.V.A.; de Greef, M. Recent advances in solution-phase multicomponent methodology for the synthesis of heterocyclic compounds. Synthesis 2003, 1471–1499. [Google Scholar]
  13. Isambert, N.; Duque, M.M.S.; Plaquevent, J.-C.; Genisson, Y.; Rodriguez, J.; Constantieux, T. For a review of MCRs in ionic liquids, multicomponent reactions and ionic liquids: A perfect synergy for eco-compatible heterocyclic synthesis. Chem. Soc. Rev. 2011, 40, 1347–1357. [Google Scholar] [CrossRef] [PubMed]
  14. Okita, T.; Isobe, M. Synthesis of the pentacyclic intermediate for dynemicin A and unusual formation of spiro-oxindole ring. Tetrahedron 1994, 50, 11143–11152. [Google Scholar] [CrossRef]
  15. Kornet, M.J.; Thio, A.P. Oxindole-3-spiropyrrolidines and -piperidines. Synthesis and local anesthetic activity. J. Med. Chem. 1976, 19, 892–898. [Google Scholar] [CrossRef] [PubMed]
  16. Skiles, J.W.; McNeil, D. Spiro indolinone beta-lactams, inhibitors of poliovirus and rhinovirus 3C-proteinases. Tetrahedron Lett. 1990, 31, 7277–7280. [Google Scholar] [CrossRef]
  17. Jossang, A.; Jossang, P.; Hadi, H.A.; Sevenet, T.; Bodo, B. Horsfiline, an oxindole alkaloid from Horsfieldia superba. J. Org. Chem. 1991, 56, 6527–6530. [Google Scholar] [CrossRef]
  18. Galliford, C.V.; Scheidt, K.A. Pyrrolidinyl-spirooxindole natural products as inspirations for the development of potential therapeutic agents. Angew. Chem. Int. Ed. Engl. 2007, 46, 8748–8758. [Google Scholar] [CrossRef] [PubMed]
  19. James, M.N.G.; Williams, G.J.B. The molecular and crystal structure of an oxindole alkaloid (6-hydroxy-2'-(2-methylpropyl)-3,3'-spirotetrahydropyrrolidino-oxindole). Can. J. Chem. 1972, 50, 2407–2412. [Google Scholar] [CrossRef]
  20. Cui, C.-B.; Kakeya, H.; Okada, G.; Onose, R.; Osada, H. Novel mammalian cell cycle inhibitors, tryprostatins A, B and other diketopiperazines produced Aspergillus fumigatus. I. Taxonomy, fermentation, isolation and biological properties. J. Antibiot. 1996, 49, 527–533. [Google Scholar] [CrossRef] [PubMed]
  21. Cui, C.-B.; Kakeya, H.; Osada, H. Novel mammalian cell cycle inhibitors, spirotryprostatins A and B, produced by Aspergillus fumigatus, which inhibit mammalian cell cycle at G2/M phase. Tetrahedron 1996, 52, 12651–12666. [Google Scholar] [CrossRef]
  22. Khafagy, M.M.; Abd El-Wahab, A.H.F.; Eid, F.A.; El-Agrody, A.M. Synthesis of halogen derivatives of benzo[h]chromene and benzo[a]anthracene with promising antimicrobial activities. Farmaco 2002, 57, 715–722. [Google Scholar] [CrossRef] [PubMed]
  23. Kang, T.H.; Matsumoto, K.; Tohda, M.; Murakami, Y.; Takayama, H.; Kitajima, M.; Aimi, N.; Watanabe, H. Pteropodine and isopteropodine positively modulate the function of rat muscarinic M1 and 5-HT2 receptors expressed in Xenopus oocyte. Eur. J. Pharmacol. 2002, 444, 39–45. [Google Scholar] [CrossRef] [PubMed]
  24. García Prado, E.; García Gimenez, M.D.; de la Puerta Vázquez, R.; Espartero Sánchez, J.L.; Sáenz Rodríguez, M.T. Antiproliferative effects of mitraphylline, a pentacyclic oxindole alkaloid of Uncaria tomentosa on human glioma and neuroblastoma cell lines. Phytomedicine 2007, 14, 280–284. [Google Scholar] [CrossRef] [PubMed]
  25. Arumugam, N.; Raghunathan, R. Facile synthesis of β-lactam-grafted spirooxindolopyrrolidine through regioselective 1,3-dipolar cycloaddition reaction. Synth. Commun. 2011, 41, 2747–2755. [Google Scholar] [CrossRef]
  26. Arumugam, N.; Jayashankaran, J.; Rathna Durga, R.S.M.; Raghunathan, R. A novel access to highly functionalised β-lactams by regio- and stereoselective 1,3-dipolar cycloaddition reaction. Tetrahedron 2005, 61, 8512–8516. [Google Scholar] [CrossRef]
  27. Arumugam, N.; Raghunathan, R.; Shanmugaiah, V.; Mathivanan, N. Synthesis of novel β-lactam fused spiroisoxazolidine chromanones and tetralones as potent antimicrobial agent for human and plant pathogens. Bioorg. Med. Chem. Lett. 2010, 20, 3698–3702. [Google Scholar] [CrossRef] [PubMed]
  28. Arumugam, N.; Periyasami, G.; Raghunathan, R.; Kamalraj, S.; Muthumary, J. Synthesis and antimicrobial activity of highly functionalised novel β-lactam grafted spiropyrrolidines and pyrrolizidines. Eur. J. Med. Chem. 2011, 46, 600–607. [Google Scholar] [CrossRef] [PubMed]
  29. Arumugam, N.; Raghunathan, R.; Almansour, A.I.; Karama, U. An efficient synthesis of highly functionalized novel chromeno[4,3-b]pyrroles and indolizino[6,7-b]indoles as potent antimicrobial and antioxidant agents. Bioorg. Med. Chem. Lett. 2012, 22, 1375–1379. [Google Scholar] [CrossRef] [PubMed]
  30. Arumugam, N.; Almansour, A.I.; Suresh Kumar, R.; Perumal, S.; Ghabbour, H.A.; Fun, H.-K. A 1,3-dipolar cycloaddition–annulation protocol for the expedient regio-, stereo- and product-selective construction of novel hybrid heterocycles comprising seven rings and seven contiguous stereocentres. Tetrahedron Lett. 2013, 55, 2515–2519. [Google Scholar] [CrossRef]
  31. Suresh Babu, A.R.; Raghunathan, R. ZrOCl·8H2O mediated microwave induced [3+2] cycloaddition of azomethine ylides-a facile one-pot synthesis of novel dispiroheterocycles. Tetrahedron Lett. 2007, 48, 305–308. [Google Scholar] [CrossRef]
  32. Suresh Babu, A.R.; Raghunathan, R. Ultrasonic assisted-silica mediated [3+2] cycloaddition of azomethine ylides-a facile multicomponent one-pot synthesis of novel dispiroheterocycles. Tetrahedron Lett. 2007, 48, 6809–6813. [Google Scholar] [CrossRef]
  33. Suresh Babu, A.R.; Raghunathan, R. An easy access to novel steroidal dispiropyrrolidines through 1,3-dipolar cycloaddition of azomethine ylides. Tetrahedron Lett. 2008, 49, 4618–4620. [Google Scholar] [CrossRef]
  34. Crystallographic data (excluding structure factors) for dispiro compound 6f in this article have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication number CCDC 1026186–1026187. Copies of the data can be obtained, free of charge, on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK [fax: +44 (0)1223 336033 or e-mail: [email protected]].
  35. Sheldrick, G.M. A short history of SHELX. Acta Crystallogr. Sect. A: Found. Crystallogr. 2008, 64, 112–122. [Google Scholar] [CrossRef]
  • Sample Availability: Samples of the compounds are available from the authors.

Share and Cite

MDPI and ACS Style

Almansour, A.I.; Arumugam, N.; Kumar, R.S.; Periyasami, G.; A. Ghabbour, H.; Fun, H.-K. A Novel One-Pot Green Synthesis of Dispirooxindolo-pyrrolidines via 1,3-Dipolar Cycloaddition Reactions of Azomethine Ylides. Molecules 2015, 20, 780-791. https://doi.org/10.3390/molecules20010780

AMA Style

Almansour AI, Arumugam N, Kumar RS, Periyasami G, A. Ghabbour H, Fun H-K. A Novel One-Pot Green Synthesis of Dispirooxindolo-pyrrolidines via 1,3-Dipolar Cycloaddition Reactions of Azomethine Ylides. Molecules. 2015; 20(1):780-791. https://doi.org/10.3390/molecules20010780

Chicago/Turabian Style

Almansour, Abdulrahman I., Natarajan Arumugam, Raju Suresh Kumar, Govindasami Periyasami, Hazem A. Ghabbour, and Hoong-Kun Fun. 2015. "A Novel One-Pot Green Synthesis of Dispirooxindolo-pyrrolidines via 1,3-Dipolar Cycloaddition Reactions of Azomethine Ylides" Molecules 20, no. 1: 780-791. https://doi.org/10.3390/molecules20010780

Article Metrics

Back to TopTop